The Department of Pharmacology congratulates Dr. Inthrani Raja Indran on her well-deserved promotion to Associate Professor, in recognition of her outstanding dedication and leadership in medical education.
Dr Inthrani has played a transformational role in enhancing student learning and mentorship since she joined NUS Medicine and her ongoing work will ensure sustainable growth of a student‑centred learning ecosystem at NUS Medicine.
In a study that holds significance for individuals with cerebrovascular disease, scientists from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found proteins in the blood that predict future cognitive decline and dementia.
Led by Professor Christopher Chen, Deputy Chair of the Healthy Longevity Translational Research Programme (TRP) at NUS Medicine, this first-of-its-kind study in Singapore analysed more than 1,000 proteins in the blood of a local patient cohort. The study was conducted on 528 patients from memory clinics at the National University Hospital (NUH) and St Luke’s Hospital in Singapore.
Professor Arthur Mark Richards, co-senior author of the paper published in Alzheimer’s and Dementia, said, “One of our findings was the characterisation of a blood protein signature for future cognitive decline. Using advanced proteomic technologies, we profiled over a thousand blood proteins tied to neurodegeneration, inflammation, and vascular dysfunction, which are key contributors to dementia.” Prof Richards is from the Cardiovascular-Metabolic Diseases TRP at NUS Medicine.
The team found that people with dysregulated levels of these proteins were more likely to develop future dementia and cognitive deterioration, even after accounting for age and other health conditions. These proteins are also linked to changes in brain structure, such as shrinkage in brain volume and signs of small vessel disease, which are early warning signs of dementia. When these biomarkers were combined with clinical risk factors, prognosis of cognitive decline was significantly enhanced, highlighting the potential of integrating blood-based tests with routine clinical assessments for earlier and more accurate diagnosis.
The team further validated these findings in a separate group of patients of Caucasian descent, using cerebrospinal fluid—which refers to fluid that surrounds the brain and spinal cord. The replicated protein markers remained strong predictors of cognitive decline, suggesting these biomarkers may be reliable across different biological fluids and diverse populations.
Congratulations to faculty members from the Department of Pharmacology featured in the latest Research.com global rankings of best scientists by discipline. These rankings recognise leading experts based on their research performance and contributions to their respective fields.
Notably, Professor Guillermo C. Bazan was ranked 1st in Singapore and 97th globally in Chemistry. Other distinguished faculty members, including A/P Gautam Sethi, Dr. Alan Prem Kumar, Dr. Mitchell Lai Kim Peng, A/P Gavin S. Dawe, Prof. Manjunatha Kini, Dr. Muthu Shanmugam, A/P Edward Manser, A/P Shabbir Moochhala, Prof. Phillip K. Moore, and Prof. Christopher Chen Li-Hsian, were also acknowledged across disciplines such as Medicine, Neuroscience, and Biology & Biochemistry.
These recognitions reflect the department’s commitment to excellence in biomedical research and its impact both locally and internationally.
Congratulations to Dr. Chandra Sekhar Bhol on receiving an award under special category for his presentation titled “From Gene to Cure: Leveraging PAX9 Against Oral Cancer” at the 31st International Cell Death Society (ICDS) Meeting.
The award was presented by Professor Dhyan Chandra from Roswell Park Comprehensive Cancer Center, New York, USA, recognizing the significance of Dr. Chandra Bhol’s research contribution.
Thinking of advancing your career in Medical Pharmacology? This is your last opportunity to join our August 2025 intake!
We’ve extended the local application deadline one final time to 20 June 2025 to accommodate final submissions.
✅ Future-focused curriculum with strong industry and academic components
✅ One-year intensive programme or Two-years at your own pace
✅ Aligned with Biotech sector growth in Singapore & Asia-Pacific
On 19th May 2025, Department of Pharmacology at the Yong Loo Lin School of Medicine hosted President Zhai Lixiang and his delegation from Guangdong Pharmaceutical University (GDPU) under an invitation by Head of Department Assoc Prof Gavin Dawe.
Assoc Prof Low Chian Ming (Deputy Head) and Assoc Prof Wang Lingzhi (MSc Admission Lead, China) extended a warm welcome to President Zhai and his team. Understanding from President Zhai that GDPU sets their mission on science-industry-education integration, the meeting involved enthusiastic and constructive discussions. It began by presentations from our department representatives Asst Prof Minh Le (research), Dr. Mitchell Lai and Dr. Mustafa (Huda) (education; SCALE short-term courses and MSc in Medical Pharmacology programme) followed by an introductory video showcasing GDPU vison and mission in education and research.
GDPU team showed strong interests in pursuing collaborations in research and education through faculty and student exchange, especially exploring plausible formats to integrate our MSc in Medical Pharmacology with their undergraduate programmes. The meeting opened exciting opportunities and strong desire to strengthen communication so as to initiate in-depth discussions between both institutions.
The Department of Pharmacology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), recently welcomed a distinguished delegation from Shanghai University (SHU), marking a vibrant exchange of ideas and the start of promising academic synergies. This visit served as a dynamic platform to deepen mutual understanding and spark new collaborative possibilities in medical science, innovation, and education.
The session began with warm welcome remarks by Assoc Prof Gavin Dawe, Head of Pharmacology at NUS Medicine, and Prof Wang Congchun, Vice President of SHU, setting an enthusiastic and collegial tone for the day. An introductory video showcasing SHU’s strengths was followed by compelling research presentations from Prof Fred Wong (NUS Medicine) and Prof Chen Liang (SHU School of Medicine). Dr Nurulhuda Mustafa also introduced our MSc in Medical Pharmacology programme, highlighting its relevance to aspiring researchers and clinicians.
Lively and forward-looking discussions explored a range of potential collaborations, from joint research grants and student exchange programmes to short-term courses for SHU undergraduates and postgraduates.
We extend our heartfelt thanks to Dr Alan Prem Kumar (NUS Medicine) for his instrumental role in coordinating this meaningful dialogue. We look forward to translating these conversations into impactful collaborations that push the boundaries of research and education.”
